Furthermore, preventive administration of L. casei BL23 suppressed cancer occurrence in vivo through systemic recruitment of NK cells, while therapeutic administration remarkably inhibited cancer cell growth through upregulation of IL-2 and activation of T cells. Here, IL2 is linked to cancer.